Abstract
Frias JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385:503-15. 34170647.
MeSH terms
-
Diabetes Mellitus, Type 2* / drug therapy
-
Gastric Inhibitory Polypeptide
-
Glucagon-Like Peptides
-
Glycated Hemoglobin / analysis
-
Humans
-
Hypoglycemic Agents / therapeutic use
Substances
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
semaglutide
-
Gastric Inhibitory Polypeptide
-
Glucagon-Like Peptides
-
tirzepatide